Search results for "V2"
showing 10 items of 446 documents
"Table 17" of "Elliptic flow of muons from heavy-flavour hadron decays at forward rapidity in Pb-Pb collisions at $\sqrt{s_{\rm NN}}=2.76$ TeV"
2015
pT-differential $v_{2}$ of muons from heavy-flavour decays extracted with Lee-Yang zeros (Sum) method.
"Table 9" of "Elliptic flow of muons from heavy-flavour hadron decays at forward rapidity in Pb-Pb collisions at $\sqrt{s_{\rm NN}}=2.76$ TeV"
2015
pT-differential inclusive muon $v_{2}$ extracted with Lee-Yang zeros (Prod) method.
"Table 8" of "Elliptic flow of muons from heavy-flavour hadron decays at forward rapidity in Pb-Pb collisions at $\sqrt{s_{\rm NN}}=2.76$ TeV"
2015
pT-differential inclusive muon $v_{2}$ extracted with Lee-Yang zeros (Sum) method.
"Table 6" of "Elliptic flow of muons from heavy-flavour hadron decays at forward rapidity in Pb-Pb collisions at $\sqrt{s_{\rm NN}}=2.76$ TeV"
2015
pT-differential inclusive muon $v_{2}$ extracted with two-particle cumulants method.
"Table 1" of "Elliptic flow of muons from heavy-flavour hadron decays at forward rapidity in Pb-Pb collisions at $\sqrt{s_{\rm NN}}=2.76$ TeV"
2015
pT-differential inclusive muon $v_{2}$ extracted with scalar product method.
"Table 3" of "Elliptic flow of muons from heavy-flavour hadron decays at forward rapidity in Pb-Pb collisions at $\sqrt{s_{\rm NN}}=2.76$ TeV"
2015
pT-differential inclusive muon $v_{2}$ extracted with scalar product method.
"Table 5" of "Elliptic flow of muons from heavy-flavour hadron decays at forward rapidity in Pb-Pb collisions at $\sqrt{s_{\rm NN}}=2.76$ TeV"
2015
pT-differential inclusive muon $v_{2}$ extracted with scalar product method.
"Table 7" of "Elliptic flow of muons from heavy-flavour hadron decays at forward rapidity in Pb-Pb collisions at $\sqrt{s_{\rm NN}}=2.76$ TeV"
2015
pT-differential inclusive muon $v_{2}$ extracted with four-particle cumulants method.
An international perspective on hospitalized patients with viral community-acquired pneumonia
2019
Background Who should be tested for viruses in patients with community acquired pneumonia (CAP), prevalence and risk factors for viral CAP are still debated. We evaluated the frequency of viral testing, virus prevalence, risk factors and treatment coverage with oseltamivir in patients admitted for CAP. Methods Secondary analysis of GLIMP, an international, multicenter, point-prevalence study of hospitalized adults with CAP. Testing frequency, prevalence of viral CAP and treatment with oseltamivir were assessed among patients who underwent a viral swab. Univariate and multivariate analysis was used to evaluate risk factors. Results 553 (14.9%) patients with CAP underwent nasal swab. Viral CA…
Kawasaki disease recurrence in the COVID-19 era: a systematic review of the literature
2021
Kawasaki disease (KD) is a vasculitis of unknown origin of small and medium caliber blood vessels, especially involving coronary arteries and is the leading cause of acquired heart disease in childhood in developed countries. Although rarely, it can recur: most recurrences occur within 2 years of the initial episode. No data are available on incidence of recurrent KD in Europe and multiple recurrences are rarely seen. We reviewed the medical literature on Kawasaki disease recurrence and reported a new case of Kawasaki disease recurrence in a child with SARS-CoV-2 infection. We believe that in our case SARS Cov2 acted as a trigger capable to determine, in a genetically susceptible individual…